• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血流介导的血管舒张与非瓣膜性心房颤动患者的心血管事件相关。

Flow-mediated dilation is associated with cardiovascular events in non-valvular atrial fibrillation patients.

作者信息

Perri Ludovica, Pastori Daniele, Pignatelli Pasquale, Violi Francesco, Loffredo Lorenzo

机构信息

I Clinica Medica, Sapienza University, Rome, Italy.

I Clinica Medica, Sapienza University, Rome, Italy.

出版信息

Int J Cardiol. 2015 Jan 20;179:139-43. doi: 10.1016/j.ijcard.2014.10.039. Epub 2014 Nov 10.

DOI:10.1016/j.ijcard.2014.10.039
PMID:25464433
Abstract

BACKGROUND

Atrial fibrillation is associated with multiple atherosclerotic risk factors and predisposes to cardiovascular events (CVE). Endothelial dysfunction is associated with atherosclerosis and independently predicts CVE. The aim of the study was to evaluate the association between endothelial dysfunction, as assessed by flow-mediated dilation (FMD), and CVE in AF patients.

METHODS

We prospectively measured FMD in 514 non-valvular AF patients on anticoagulant treatment with vitamin K antagonists. Patients were followed-up for a mean time of 23.5 months. The main composite outcome of the study was the occurrence of stroke/TIA, myocardial infarction, urgent revascularization and cardiovascular death.

RESULTS

Median value of FMD was 4.6% [IQR 1.46-8.00]. A CVE occurred in 44 patients (8.56%):non-fatal myocardial infarction (MI) in 7, fatal MI in 2, stent/coronary artery by-pass graft (CABG) in 10, ischemic non-fatal stroke in 10, fatal stroke in 3, transient ischemic attack (TIA) in 1, and cardiovascular death in 11 patients. Patients who experienced a CVE showed significantly reduced FMD compared to those who did not (3.06% [IQR 0.00-6.00] vs 4.67% [IQR 1.58-8.22], p=0.027). During a mean follow-up of 23.5 months, the rate of CVE was significantly higher in subjects with FMD below median (<4.6%) than in those with FMD above median (27 vs 17, log-rank test p=0.006). COX analysis demonstrated that low FMD (below median) (HR: 2.20, CI 95%:1.13-4.28, p=0.020), age (HR: 1.08, CI 95%: 1.03-1.12, p<0.001), smoking (HR: 4.15, CI 95%: 1.63-10.6, p=0.003) and history of stroke/TIA (HR: 2.38, CI 95%: 1.13-5.04, p=0.023) independently predicted CVE.

CONCLUSIONS

In AF patients low FMD is associated with increased risk of CVE suggesting that impaired artery dilatation predisposes to atherosclerotic complications.

摘要

背景

心房颤动与多种动脉粥样硬化危险因素相关,并易引发心血管事件(CVE)。内皮功能障碍与动脉粥样硬化相关,且可独立预测CVE。本研究旨在评估通过血流介导的血管舒张(FMD)评估的内皮功能障碍与房颤患者CVE之间的关联。

方法

我们前瞻性地测量了514例接受维生素K拮抗剂抗凝治疗的非瓣膜性房颤患者的FMD。患者平均随访23.5个月。本研究的主要复合结局是中风/短暂性脑缺血发作(TIA)、心肌梗死、紧急血运重建和心血管死亡的发生。

结果

FMD的中位数为4.6%[四分位间距1.46 - 8.00]。44例患者(8.56%)发生了CVE:7例非致命性心肌梗死(MI),2例致命性MI,10例行支架/冠状动脉搭桥术(CABG),10例缺血性非致命性中风,3例致命性中风,1例短暂性脑缺血发作(TIA),11例心血管死亡。发生CVE的患者与未发生CVE的患者相比,FMD显著降低(3.06%[四分位间距0.00 - 6.00] vs 4.67%[四分位间距1.58 - 8.22],p = 0.027)。在平均23.5个月的随访期间,FMD低于中位数(<4.6%)的受试者CVE发生率显著高于FMD高于中位数者(27例对17例;对数秩检验p = 0.006)。COX分析表明,低FMD(低于中位数)(风险比:2.20,95%置信区间:1.13 - 4.28,p = 0.020)、年龄(风险比:1.08,95%置信区间:1.03 - 1.12,p < 0.001)、吸烟(风险比:4.15,95%置信区间:1.63 - 10.6,p = 0.003)和中风/TIA病史(风险比:2.38,95%置信区间:1.13 - 5.04,p = 0.023)可独立预测CVE。

结论

在房颤患者中,低FMD与CVE风险增加相关,提示动脉扩张受损易引发动脉粥样硬化并发症。

相似文献

1
Flow-mediated dilation is associated with cardiovascular events in non-valvular atrial fibrillation patients.血流介导的血管舒张与非瓣膜性心房颤动患者的心血管事件相关。
Int J Cardiol. 2015 Jan 20;179:139-43. doi: 10.1016/j.ijcard.2014.10.039. Epub 2014 Nov 10.
2
Long-term association of brachial artery flow-mediated vasodilation and cardiovascular events in middle-aged subjects with no apparent heart disease.无明显心脏病的中年受试者肱动脉血流介导的血管舒张与心血管事件的长期关联。
Int J Cardiol. 2009 May 1;134(1):52-8. doi: 10.1016/j.ijcard.2008.01.021. Epub 2008 May 13.
3
Urinary 11-dehydro-thromboxane B2 is associated with cardiovascular events and mortality in patients with atrial fibrillation.尿11-脱氢血栓素B2与心房颤动患者的心血管事件及死亡率相关。
Am Heart J. 2015 Sep;170(3):490-7.e1. doi: 10.1016/j.ahj.2015.05.011. Epub 2015 May 22.
4
Incidence of myocardial infarction and vascular death in elderly patients with atrial fibrillation taking anticoagulants: relation to atherosclerotic risk factors.老年房颤患者抗凝治疗后心肌梗死和血管死亡的发生率:与动脉粥样硬化危险因素的关系。
Chest. 2015 Jun;147(6):1644-1650. doi: 10.1378/chest.14-2414.
5
Inadequate anticoagulation by Vitamin K Antagonists is associated with Major Adverse Cardiovascular Events in patients with atrial fibrillation.维生素K拮抗剂抗凝不足与心房颤动患者的主要不良心血管事件相关。
Int J Cardiol. 2015 Dec 15;201:513-6. doi: 10.1016/j.ijcard.2015.08.054. Epub 2015 Aug 5.
6
Usefulness of brachial artery flow-mediated dilation to predict long-term cardiovascular events in subjects without heart disease.无心脏病受试者的肱动脉血流介导扩张对预测长期心血管事件的作用。
Am J Cardiol. 2014 Jan 1;113(1):162-7. doi: 10.1016/j.amjcard.2013.08.051. Epub 2013 Oct 5.
7
Cholesterol-adjusted vitamin E serum levels are associated with cardiovascular events in patients with non-valvular atrial fibrillation.调整胆固醇后的维生素 E 血清水平与非瓣膜性心房颤动患者的心血管事件相关。
Int J Cardiol. 2013 Oct 9;168(4):3241-7. doi: 10.1016/j.ijcard.2013.04.142. Epub 2013 May 5.
8
The impact of early compared to late morning hours on brachial endothelial function and long-term cardiovascular events in healthy subjects with no apparent coronary heart disease.与清晨相比,早期对无明显冠心病的健康受试者肱动脉内皮功能和长期心血管事件的影响。
Int J Cardiol. 2011 Sep 15;151(3):342-7. doi: 10.1016/j.ijcard.2010.08.069. Epub 2010 Sep 15.
9
Impaired flow mediated dilatation as evidence of endothelial dysfunction in chronic atrial fibrillation: relationship to plasma von Willebrand factor and soluble E-selectin levels.血流介导的血管舒张功能受损作为慢性心房颤动内皮功能障碍的证据:与血浆血管性血友病因子和可溶性E选择素水平的关系。
Thromb Res. 2008;122(1):85-90. doi: 10.1016/j.thromres.2007.09.008. Epub 2007 Nov 8.
10
The CHADS2 and CHA2DS2-VASc scores predict adverse vascular function, ischemic stroke and cardiovascular death in high-risk patients without atrial fibrillation: role of incorporating PR prolongation.CHADS2和CHA2DS2-VASc评分可预测无房颤的高危患者的不良血管功能、缺血性卒中和心血管死亡:纳入PR间期延长的作用。
Atherosclerosis. 2014 Dec;237(2):504-13. doi: 10.1016/j.atherosclerosis.2014.08.026. Epub 2014 Aug 30.

引用本文的文献

1
Atrial Fibrillation and Early Vascular Aging: Clinical Implications, Methodology Issues and Open Questions-A Review from the VascAgeNet COST Action.心房颤动与血管早期老化:临床意义、方法学问题及待解决问题——来自VascAgeNet COST行动的综述
J Clin Med. 2024 Feb 20;13(5):1207. doi: 10.3390/jcm13051207.
2
Relationship Between Endothelial Dysfunction and the Outcomes After Atrial Fibrillation Ablation.**关键词**:心房颤动消融术;内皮功能障碍;结局 **译文**:心房颤动消融术后内皮功能障碍与结局的关系
J Am Heart Assoc. 2023 Jun 6;12(11):e028482. doi: 10.1161/JAHA.122.028482. Epub 2023 May 26.
3
Aging-Related Decline of Autophagy in Patients with Atrial Fibrillation-A Post Hoc Analysis of the ATHERO-AF Study.
心房颤动患者自噬的衰老相关衰退——ATHERO-AF研究的事后分析
Antioxidants (Basel). 2022 Apr 1;11(4):698. doi: 10.3390/antiox11040698.
4
The Effects of Ischemic Preconditioning Supplementation on Endothelial Function: A Systematic Review and Meta-Analysis.缺血预处理补充对内皮功能的影响:系统评价与荟萃分析
Evid Based Complement Alternat Med. 2021 Jul 26;2021:6690691. doi: 10.1155/2021/6690691. eCollection 2021.
5
A Review of Biomarkers for Ischemic Stroke Evaluation in Patients With Non-valvular Atrial Fibrillation.非瓣膜性心房颤动患者缺血性卒中评估生物标志物综述
Front Cardiovasc Med. 2021 Jul 1;8:682538. doi: 10.3389/fcvm.2021.682538. eCollection 2021.
6
Vascular function in continuous-flow left ventricular assist device recipients: effect of a single pulsatility treatment session.连续血流左心室辅助装置接受者的血管功能:单次搏动治疗的效果。
Am J Physiol Regul Integr Comp Physiol. 2021 Apr 1;320(4):R425-R437. doi: 10.1152/ajpregu.00274.2020. Epub 2021 Jan 13.
7
Applying the CHADS-VASc score to predict the risk of future acute coronary syndrome in patients receiving catheter ablation for atrial fibrillation.应用CHADS-VASc评分预测接受房颤导管消融术患者未来发生急性冠状动脉综合征的风险。
Int J Cardiol Heart Vasc. 2020 Jun 28;29:100567. doi: 10.1016/j.ijcha.2020.100567. eCollection 2020 Aug.
8
Endothelial function in patients with atrial fibrillation.心房颤动患者的血管内皮功能。
Ann Med. 2020 Feb-Mar;52(1-2):1-11. doi: 10.1080/07853890.2019.1711158. Epub 2020 Jan 10.
9
Predictive value of CHADS and CHADS-VASc scores for acute myocardial infarction in patients with atrial fibrillation.CHA2DS2-VASc 评分对合并心房颤动患者急性心肌梗死的预测价值。
Sci Rep. 2017 Jul 5;7(1):4730. doi: 10.1038/s41598-017-04604-w.
10
Atrial Fibrillation and Myocardial Infarction: A Systematic Review and Appraisal of Pathophysiologic Mechanisms.心房颤动与心肌梗死:病理生理机制的系统评价与评估
J Am Heart Assoc. 2016 May 20;5(5):e003347. doi: 10.1161/JAHA.116.003347.